Share of people vaccinated against COVID-19 worldwide

Proporción de personas vacunadas contra COVID-19 a nivel mundial

Main Article Content

Jorge Enrique Díaz Pinzón

Abstract

Introduction: the equitable path to safe and effective vaccines is paramount to bring the COVID-19 pandemic to an end. Thus, it is reassuring that so many vaccines are being tested and developed. The WHO (World Health Organization), together with its partners, is working hard to develop, manufacture and distribute safe and effective vaccines. Methodology: the present research is a cross-sectional study. Data was taken from the Our World in Data website, based on the global vaccination plan against COVID-19. Results: it was established that as of August 6 2021, the countries with the highest share of allocated vaccines and fully vaccinated people were: the United Arab Emirates (72), Uruguay (66), Chile (65), Bahrain (62) and Israel (62). Those with the highest percentage of applied vaccination doses were: Argentina (39), Brazil (31), Saudi Arabia (29), South Korea (25.5)  and Malasya (22). Conclusion:  it is imperative that both the allocation of doses of vaccines against SARS-COV-2 and the vaccine application capacity continue to be increased in all countries of the world, underlining the importance of completing the recommended vaccination protocols, in order to achieve herd immunity worldwide in the short term.

Keywords:

Downloads

Download data is not yet available.

Article Details

Author Biography

Jorge Enrique Díaz Pinzón, Secretaría de Educación de Soacha

Ingeniero. Magister en Gestión de la Tecnología Educativa, Especialista en Administración de la Informática Educativa. Docente de matemáticas e Investigador.

References

Our World in Data. Statistics and Research Coronavirus (COVID-19) Vaccinations [Internet]. 2021 [consultado 7 May 2021]. Disponible en: https://ourworldindata.org/covid-vaccinations

World Health Organization. COVID-19 vaccines [Internet]. 2021 [consultado 7 May 2021]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines

Casas I, Mena G. La vacunación de la COVID-19. Medicina Clínica. 2021;156(10):500-2. doi: 10.1016/j.medcli.2021.03.001

COVID-19 vaccination and prioritization strategies in the EU/EEA [Internet]. European Centre for Disease Prevention and Control. 2020 [citado 7 May 2021] Disponible en: https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccination-and-prioritisation-strategies-eueea

Ministerio de Sanidad, Consumo y Bienestar Social. Estrategia de vacunación COVID-19 en España [Internet]. España; 2021 [consultado 7 May 2021]. Disponible en:https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/vacunaCovid19.htm

Dreser A. Retos y avances en la vacunación contra COVID-19 en Latinoamérica y el Caribe. Salud UIS. 2021;53:e21002. doi: https://doi.org/10.18273/saluduis.53.e:21002

Kim J, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021;27:205–211. doi: 10.1038/s41591-021-01230-y

Díaz Pinzón JE. Estimación de la prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99–102. doi: https://doi.org/10.31260/RepertMedCir.01217372.1115

Díaz Pinzón JE. Análisis de los resultados del contagio del COVID-19 respecto a su distribución geográfica en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):60-64. https://doi.org/10.31260/RepertMedCir.01217372.1082

Díaz Pinzón JE. Dinámica y relación del contagio del COVID-19 después de iniciado el plan de vacunación contra el SARS-COV-2 en Colombia. Repert Med Cir. 2021;30(Núm. Supl.1):41–45. https://doi.org/10.31260/RepertMedCir.01217372.1227

Citado por